With the strategy of building EU-GMP-standard factories and prioritising scientific research, Imexpharm has gained a leading ...

Supported by a team of leading talents in the pharmaceutical industry, Imexpharm is set for major advancements.

The pharmaceutical business community expects that the draft amendments to the Law on Pharmacy 2016 will be adopted by the ...

We recently compiled a list of the 15 Worst 52-Week Low Stocks to Buy Now According to Short Sellers. In this article, we are ...

Acumen Health Holdings, LLC, a professionally recommended, consumer-preferred dietary supplements company focused on eye health and companion animals, announced today that its subsidiary, PRN ...

Vertex Pharmaceuticals announced the first accepted ... investors are keenly watching high-growth tech stocks that can capitalize on these dynamic market conditions. In this context, a good ...

Catalyst Pharmaceuticals’ primary revenue driver ... Investment in Catalyst should be cautious given the high valuation and significant reliance on Firdapse, making the company vulnerable ...

Pharmaceutical companies have stereotypically been painted as greedy, with people often pointing to the high prices that many ... Its current client list and tech-first approach is good enough ...

Future of Healthcategory US FDA approves GE HealthCare's diagnostic drug for heart disease September 27, 2024 Healthcare & Pharmaceuticalscategory US farmers call for vaccine option to fight bird ...

1 Day 301130 -0.75% DJIA 0.15% S&P Mid Cap 400 0.52% Health Care/Life Sciences -0.04% ...

In 2022, Green Pharmaceuticals got warnings from the FDA and issued a recall due to microbial contamination in its SnoreStop ...